Cardiometabolic Health Congress (CMHC) Concludes 13th Annual Event in Boston

    NEXT STORY
    Health Care Administrators Association (HCAA) Announces Speaker Lineup for 2019 Executive Forum
    PREV STORY
    Presentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update

    ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an ...

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech Set to Reach Three Major Milestones in 2020

    author_avatar
    NASDAQ Market News

    Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed

    PLYMOUTH MEETING, Pa., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

    author_avatar
    NASDAQ Market News